Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Chelliah, Selvam"'
Autor:
Chintamaneni, Pavan Kumar, Pindiprolu, Sai Kiran S.S., Swain, Swati Swagatika, Karri, Veera Venkata Satyanarayana Reddy, Nesamony, Jerry, Chelliah, Selvam, Bhaskaran, Mahendran
Publikováno v:
In Cancer Letters 28 April 2024 588
Development and application of LC-MS/MS method for the quantification of hydrogen sulfide in the eye
Autor:
Okolie, Anthonia, Nigro, Maria Rincon, Polk, Sharhazad, Stubbs, Keyona, Chelliah, Selvam, Ohia, Sunny E., Liang, Dong, Mbye, Ya Fatou Njie
Publikováno v:
In Analytical Biochemistry April 2024 687
Autor:
Priya Deivasigamani, S. M. Esther Rubavathy, Narayanan Jayasankar, Venkatesan Saravanan, Ramasamy Thilagavathi, Muthuramalingam Prakash, Chelliah Selvam, Rajakrishnan Rajagopal, Ahmed Alfarhan, Muthu Kumaradoss Kathiravan, Selvaraj Arokiyaraj, Jesu Arockiaraj
Publikováno v:
Biomedicines, Vol 12, Iss 4, p 788 (2024)
A series of novel 1,5-diaryl pyrazole derivatives targeting the COX enzyme were designed by combined ligand and structure-based approach. The designed molecules were then further subjected to ADMET and molecular docking studies. Out of 34 designed co
Externí odkaz:
https://doaj.org/article/c3942722b6be4cd6b55befe26211d0d3
Autor:
Ramasamy Thilagavathi, S. Sameema Begum, Sowfika Dharshini Varatharaj, Arun kumar Balasubramaniam, Joselin Susan George, Chelliah Selvam
Publikováno v:
Phytotherapy Research. 37:2102-2118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f26e975bf90419632aaed932ab4d815
https://doi.org/10.1002/ptr.7821
https://doi.org/10.1002/ptr.7821
Publikováno v:
Toxicology and Environmental Health Sciences. 15:85-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c6bb41eacf258025848c1ebc5b5bb39
https://doi.org/10.1007/s13530-022-00164-3
https://doi.org/10.1007/s13530-022-00164-3
Autor:
Kandhan Palanisamy, K. Rudharachari Maiyelvaganan, Shanmugasundaram Kamalakannan, Ramasamy Thilagavathi, Chelliah Selvam, Muthuramalingam Prakash
Publikováno v:
Molecular Simulation. 49:175-185
Respiratory illness due to SARS-CoV-2 emerged in 2019 and has a significant morbidity and mortality rate. The main protease (Mpro) is mainly responsible for the viral replications, which acts as a good drug target to inhibit SARS-CoV-2 related diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e88a24c47398ac1451c8c691c52cf6
https://doi.org/10.1080/08927022.2022.2136392
https://doi.org/10.1080/08927022.2022.2136392
Publikováno v:
ChemistrySelect. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4320adf70babbb62eab13e8024e583a2
https://doi.org/10.1002/slct.202204909
https://doi.org/10.1002/slct.202204909
Autor:
Kandhan Palanisamy, S. M. Esther Rubavathy, Muthuramalingam Prakash, Ramasamy Thilagavathi, Maryam S. Hosseini-Zare, Chelliah Selvam
Publikováno v:
RSC Advances. 12:3687-3695
The recalcitrant spread of the COVID-19 pandemic produced by the novel coronavirus SARS-CoV-2 is one of the most destructive occurrences in history. Despite the availability of several effective vaccinations and their widespread use, this line of imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a9562071e7b315cf997854e63e8905
https://doi.org/10.1039/d1ra08604a
https://doi.org/10.1039/d1ra08604a
Autor:
Sridhar Priyankha, Varatharaj Rajapandian, Kandhan Palanisamy, S. M. Esther Rubavathy, Ramasamy Thilagavathi, Chelliah Selvam, Muthuramalingam Prakash
Triple-negative breast cancer (TNBC) is the most aggressive kind of breast cancer known to mankind. It is a heterogeneous disease that is formed due to the missing estrogen, progesterone and human epidermal growth factor 2 receptors. Poly(ADP-ribose)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3342a9242d3df1fae3ec3ffdc9466050
Autor:
Ramasamy Thilagavathi, Sridhar Priyankha, Manivel Kannan, Muthuramalingam Prakash, Chelliah Selvam
Publikováno v:
Chemical biologydrug designREFERENCES.
Triple-negative breast cancer (TNBC) is caused due to the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor 2 (HER2) expression. Triple-negative breast cancer is the most aggressive heterogeneous disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41982498749e737f9aabb3cce5e48d67
https://pubmed.ncbi.nlm.nih.gov/36323650
https://pubmed.ncbi.nlm.nih.gov/36323650